Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy. However, a s...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2025-08-01
|
| coleção: | Annals of Clinical and Translational Neurology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/acn3.70095 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|